Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXW0OI
|
||||
| Drug Name |
(S)-1-[4-(4-Methoxy-benzo[b]thiophen-2-yl)-2,2-dimethyl-piperidin-1-yl]-3-(2-methyl-1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL125349
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H34N2O3S
|
||||
| Canonical SMILES |
COc1cccc2sc(cc12)C3CCN(C[C@H](O)COc4cccc5[nH]c(C)cc45)C(C)(C)C3
|
||||
| InChI |
InChI=1S/C28H34N2O3S/c1-18-13-21-23(29-18)7-5-9-25(21)33-17-20(31)16-30-12-11-19(15-28(30,2)3)27-14-22-24(32-4)8-6-10-26(22)34-27/h5-10,13-14,19-20,29,31H,11-12,15-17H2,1-4H3/t19?,20-/m0/s1
|
||||
| InChIKey |
SHXLANFHNUNXHR-ANYOKISRSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.